Hurşitoğlu, O. Et Al. 2022. Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY AND BIOLOGICAL PSYCHIATRY AN INTERNATIONAL RESEARCH, REVIEW, AND NEWS JOURNAL , vol.8 , 121-129.

Hurşitoğlu, O., Belge Kurutaş, E., Strawbridge, R., Oner, ., Güngör, M., Tuman, T. C., ... Uygur, Ö. F.(2022). Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY AND BIOLOGICAL PSYCHIATRY AN INTERNATIONAL RESEARCH, REVIEW, AND NEWS JOURNAL , vol.8, 121-129.

Hurşitoğlu, Onur Et Al. "Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients," PROGRESS IN NEURO-PSYCHOPHARMACOLOGY AND BIOLOGICAL PSYCHIATRY AN INTERNATIONAL RESEARCH, REVIEW, AND NEWS JOURNAL , vol.8, 121-129, 2022

Hurşitoğlu, Onur Et Al. "Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients." PROGRESS IN NEURO-PSYCHOPHARMACOLOGY AND BIOLOGICAL PSYCHIATRY AN INTERNATIONAL RESEARCH, REVIEW, AND NEWS JOURNAL , vol.8, pp.121-129, 2022

Hurşitoğlu, O. Et Al. (2022) . "Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients." PROGRESS IN NEURO-PSYCHOPHARMACOLOGY AND BIOLOGICAL PSYCHIATRY AN INTERNATIONAL RESEARCH, REVIEW, AND NEWS JOURNAL , vol.8, pp.121-129.

@article{article, author={Onur Hurşitoğlu Et Al. }, title={Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients}, journal={PROGRESS IN NEURO-PSYCHOPHARMACOLOGY AND BIOLOGICAL PSYCHIATRY AN INTERNATIONAL RESEARCH, REVIEW, AND NEWS JOURNAL}, year=2022, pages={121-129} }